Show Notes
This episode of the Irish Haematology Oncology Podcast delves into common but potentially devastating complications of cancer treatment: febrile neutropenia, chemotherapy-induced thrombocytopenia, and chemotherapy-induced anemia. We break down the medical jargon, explore risk factors, and discuss early detection and treatment strategies. Whether you're new to oncology or seeking a refresher, this episode equips you with essential knowledge to provide the best possible care for your patients facing these challenges.
Podcast Show Notes:
Topic: Febrile neutropenia, chemotherapy-induced thrombocytopenia, chemotherapy-induced anemia
Key Points:
Understanding the terminology and mechanisms behind these complications
Identifying patients at higher risk
Importance of early detection and rapid response
Overview of treatment strategies, including antibiotics, G-CSF, and supportive care
Emerging therapies and the role of personalized medicine
Resources:
ESMO Clinical Practice Guidelines for the management of febrile neutropenia
NCCN Guidelines for Chemotherapy-Induced Thrombocytopenia
Patient education materials on febrile neutropenia, thrombocytopenia, and anemia
Additional Notes:
CPD document for IIOP requirements available here: https://docs.google.com/document/d/1b3ZZoTS-pLLVrxKB1_8-AYh4enNwUusg5mEljKiKE1k/edit?usp=sharing
Podcast now available on YouTube and LinkedIn: https://www.youtube.com/@EoinTabb
www.linkedin.com/in/eointabb
Feedback Form: https://forms.gle/skwi7x6qpuDtQCUp8
Disclaimer: This podcast is for educational purposes only. Consult with your team for personalized guidance.
More from Irish Haematology Oncology Podcast
Eoin Tabb reports from Day 3 of the ISOPP CAPhO 2025 Symposium in Victoria, Canada. This episode delves into crucial discussions on Equity, Diversity, and Inclusion (EDI) in pharmacy practice, the benefits and risks of Artificial Intelligence (AI) in oncology, updates on preventing Cancer-Associated Thrombosis (CAT), and the implementation of pre-therapeutic Pharmacogenomics (PGx), including combining DPYD testing with Therapeutic Drug Monitoring (TDM) for 5-FU. Plus, hear exciting news from the ISOPP AGM about next year's unique 24-hour virtual conference format and a special collaboration with the Irish Pharmacy Haematology Oncology Society (IPHOS)! #ISOPPCAPhO2025 #OncologyPharmacy #Haematology #ClinicalPharmacy #EDI #AI #PGx #TDM #CAT CAT Survey: https://redcap.alfredhealth.org.au/redcap/surveys/index.php?s=dFo7DpNgVBauTYeW&__startover=1
Join Eoin Tabb for the second daily dispatch from the ISOPP CAPhO 2025 Symposium in Victoria, Canada. Day 2 covered a wide spectrum of crucial topics for haematology/oncology pharmacy practice. Highlights include practical management strategies for PARP inhibitors, the importance of cultural humility and discussing traditional medicines, ISOPP's new global service level framework, pharmacy's role in disaster preparedness and environmental sustainability, efficiencies in myeloma treatment administration (pre-meds, infusion times, schedules), managing CMV infections, considerations for treating older/unfit patients using geriatric assessment, and critical updates on hazardous drug lists and safety. Tune in for key insights and takeaways relevant to Irish practice! #ISOPPCAPhO2025 #OncologyPharmacy #Haematology #ClinicalPharmacy PARPi Clinical Resource: https://cdn.ymaws.com/www.cano-acio.ca/resource/resmgr/endorsements/en_parp_inhibitor_clinical_r.pdf
Join host Eoin Tabb for a special dispatch episode recorded live from the ISOPP 2025 Symposium in Victoria, BC. Get your 'audio delegate bag' with key insights from Day 1, covering: